Apollomics APLM
NASDAQ APLM
$18.60 +0.35 (+1.92%)
As of: Nov 10, 2026 · 1:27 PM EST

Apollomics (APLM) Operating Leases (2021 - 2025)

Updated

Apollomics (APLM) posted Operating Leases of $434,000 for Q4 2025, down 40.8% from $733,000 a year earlier.

Analysis

Apollomics (APLM) Operating Leases (2021 - 2025) Analysis & Trends

Since Q4 2021, Apollomics has reported Operating Leases for 8 quarters.

  • Annual Operating Leases shows a four-year compound annual growth rate of -4.8% (FY2021 to FY2025).
  • In prior years, Apollomics' Operating Leases was $733,000 in FY2024 (+174.5%), $267,000 in FY2023 (-29.2%), $377,000 in FY2022 (-28.6%) and $528,000 in FY2021.
  • The Q4 2025 figure stands as the lowest quarterly Operating Leases since Q4 2023.
  • On a year-over-year basis, Operating Leases increased in two of the last four quarters, with growth averaging 78.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Apollomics 40.08 Mn -1.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 434,000.00
Jun 30, 2025 541,000.00
Dec 31, 2024 733,000.00
Jun 30, 2024 951,000.00
Dec 31, 2023 267,000.00
Jun 30, 2023 294,000.00
Dec 31, 2022 377,000.00
Dec 31, 2021 528,000.00
API Access

Apollomics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=APLM&period=max&api_key=YOUR_API_KEY